Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library

Elisa Beghetto1, Francesca De Paolis, Francesca Montagnani

  • 1Kenton laboratories, Kenton S.r.l., Rome, Italy.

Microbes and Infection
|November 11, 2008
PubMed

Insights

This study identified novel Mycoplasma pneumoniae antigens. Researchers used lambda display technology to find bacterial proteins recognized by antibodies, aiding in understanding atypical pneumonia.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Mycoplasma pneumoniae causes atypical pneumonia globally in children and young adults.
  • Infection involves chronic onset and recovery, with both humoral and cell-mediated immune responses.
  • Identifying specific bacterial antigens is crucial for understanding host-pathogen interactions.

Purpose of the Study:

  • To identify bacterial proteins recognized by host antibody responses in Mycoplasma pneumoniae infections.
  • To discover novel immunogenic polypeptides and map epitopes targeted by human antibodies.
  • To validate lambda display technology for antigen and epitope discovery.

Main Methods:

  • Construction and screening of a whole-genome Mycoplasma pneumoniae library displayed on lambda bacteriophage.
  • Incubation of the library with sera from patients hospitalized with mycoplasmal pneumonia.
  • Identification of recombinant bacteriophages displaying B-cell epitopes.

Main Results:

  • Confirmed the immunogenicity of known Mycoplasma pneumoniae antigens, P1 and P30 adhesins.
  • Localized immunodominant epitopes recognized by human immunoglobulins within antigen sequences.
  • Identified four novel immunogenic polypeptides encoded by MPN152, MPN426, MPN456, and MPN-500 open reading frames.

Conclusions:

  • Lambda display technology is effective for identifying Mycoplasma pneumoniae antigens and epitopes.
  • The study identified novel immunogenic targets, advancing the understanding of Mycoplasma pneumoniae pathogenesis.
  • Findings contribute to the potential development of new diagnostic or therapeutic strategies.